Last Price$7.00.0%
Market Cap$9,645.8M
LTM Net Income
($1,967.6M)
YoY Growth
N/A
3Y CAGR
N/A
5Y CAGR
N/A
Stock quality & Intrinsic value
5/10
54.0% overvalued
Natura &Co Holding S.A. Net Income
Annual
Quarterly
LTM
Crunching data... Almost there!
| Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $448.7M | $391.6M | $311.8M | $156.4M | $85.4M | $209.7M | $150.8M | $39.4M | ($101.8M) | $194.1M | ($479.7M) | ($664.1M) |
Overvalued or undervalued?
Check the intrinsic value for NTCO
and see if it's the right time to invest.
Natura &Co Holding S.A. (NTCO) Net Income comparison analysis
General
LTM Net Income
Growth
Company name
YoY growth
3Y CAGR
5Y CAGR
Natura &Co Holding S.A.NTCO
($1,967.6M)
N/A
N/A
N/A
Median Peer Set
$807.7M
0.0%
1.1%
0.0%
The Procter & Gamble CompanyPG
$15.5B
4.8%
2.2%
26.3%
Unilever PLCUL
$13.2B
(8.3%)
(7.4%)
4.1%
Colgate-Palmolive CompanyCL
$2,890.0M
25.7%
10.1%
4.1%
Kimberly-Clark CorporationKMB
$2,545.0M
49.9%
11.9%
3.4%
Kenvue Inc.KVUE
$1,030.0M
(32.5%)
35.8%
N/A
Church & Dwight Co., Inc.CHD
$585.3M
(22.5%)
(10.9%)
(1.0%)
The Clorox CompanyCLX
$457.0M
457.3%
22.8%
(10.9%)
Hims & Hers Health, Inc.HIMS
$126.0M
N/A
N/A
N/A
Coty Inc.COTY
$10.2M
(96.8%)
(68.2%)
N/A
The Estée Lauder Companies Inc.EL
($700.0M)
N/A
N/A
N/A
NTCO key stats
USD
BRL
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 3,256.1 0.0% | 3,257.7 0.1% | 3,151.9 (3.2%) | 2,405.6 (23.7%) | 2,278.7 (5.3%) | 3,082.1 35.3% | 3,683.8 19.5% | 3,661.4 (0.6%) | 7,221.0 97.2% | 7,438.1 3.0% | 7,036.5 (5.4%) | 5,344.0 (24.1%) |
| Cost of Goods Sold (COGS) | 958.5 | 981.0 | 957.3 | 784.6 | 757.5 | 910.6 | 1,040.1 | 1,022.4 | 2,587.4 | 2,594.8 | 2,546.5 | 1,933.8 |
% margin | 2,297.5 70.6% | 2,276.7 69.9% | 2,194.6 69.6% | 1,621.1 67.4% | 1,521.2 66.8% | 2,171.5 70.5% | 2,643.7 71.8% | 2,639.0 72.1% | 4,633.6 64.2% | 4,843.3 65.1% | 4,489.9 63.8% | 3,410.2 63.8% |
| Operating Expenses | 1,610.6 | 1,679.1 | 1,710.3 | 1,258.4 | 1,229.0 | 1,642.5 | 2,206.0 | 2,295.8 | 4,336.9 | 4,385.8 | 4,500.0 | 3,441.1 |
| Research & Development Expenses (R&D) | 81.5 | 85.1 | 92.8 | 63.6 | 22.1 | 25.0 | 28.2 | 22.7 | 52.9 | 41.4 | 52.9 | 32.3 |
| Selling, General & Administrative Expenses (SG&A) | 1,588.2 | 1,620.8 | 1,622.4 | 1,258.4 | 1,225.0 | 1,720.8 | 2,140.7 | 2,230.9 | 4,235.9 | 4,185.9 | 4,349.0 | 2,883.9 |
% margin | 702.0 21.6% | 653.7 20.1% | 578.7 18.4% | 362.7 15.1% | 292.2 12.8% | 425.0 13.8% | 345.5 9.4% | 838.7 22.9% | 691.7 9.6% | 428.6 5.8% | (5.5) (0.1%) | (30.9) (0.6%) |
| Interest Income | 20.8 | 13.1 | 17.9 | 15.2 | 18.3 | 51.4 | 35.6 | 495.8 | 926.7 | 49.0 | 104.0 | 0.0 |
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 121.3 | 173.6 | 708.7 | 1,129.2 | 158.6 | 144.1 | 300.2 |
| Pre-tax Income | 666.2 | 584.5 | 466.5 | 266.6 | 122.9 | 303.8 | 185.2 | 77.2 | (48.1) | 16.9 | (456.6) | (533.3) |
% effective tax rate | 217.5 32.7% | 190.5 32.6% | 151.1 32.4% | 107.4 40.3% | 34.2 27.8% | 94.1 31.0% | 34.4 18.6% | 37.8 48.9% | 53.7 (111.8%) | (194.1) (1,148.4%) | 23.2 (5.1%) | (17.3) 3.2% |
% margin | 448.7 13.8% | 391.6 12.0% | 311.8 9.9% | 156.4 6.5% | 85.4 3.7% | 209.7 6.8% | 150.8 4.1% | 39.4 1.1% | (101.8) (1.4%) | 194.1 2.6% | (479.7) (6.8%) | (664.1) (12.4%) |
| EPS | 21.25 | 18.67 | 14.83 | 7.49 | 4.01 | 9.88 | 7.22 | 1.87 | (3.37) | 5.77 | (14.37) | 17.70 |
| Diluted EPS | 21.25 | 18.67 | 14.83 | 7.49 | 4.01 | 9.88 | 7.10 | 1.87 | (3.37) | 5.69 | (14.37) | 17.62 |
% margin | 873.4 26.8% | 720.0 22.1% | 652.2 20.7% | 471.2 19.6% | 301.9 13.2% | 569.6 18.5% | 535.7 14.5% | 544.5 14.9% | 819.1 11.3% | 765.8 10.3% | 113.7 1.6% | 84.2 1.6% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is Natura &Co Holding S.A.'s Net Income?
As of today, Natura &Co Holding S.A.'s last 12-month Net Income is ($1,967.6M), based on the financial report for Sep 30, 2024 (Q3’2024).
2) What is Natura &Co Holding S.A.'s Net Income growth rate?
Over the last year, Natura &Co Holding S.A.'s Net Income growth was N/A. The average annual Net Income growth rates for Natura &Co Holding S.A. have been N/A over the past three years, N/A over the past five years.